Home » Topics » Regulatory

Regulatory
RSS

IND filed for nasal leuprolide as endometriosis therapy

Feb. 3, 2000

NDA filed for once-daily didanosine capsules

Feb. 2, 2000

FDA advisory committee recommends approval of Novantrone for MS indication

Feb. 1, 2000

Access to begin phase II trial of OraRinse for treatment and prevention of mucositis

Jan. 31, 2000

Schering-Plough seeks E.U. approval of Caelyx for treatment of advanced ovarian cancer

Jan. 28, 2000

Beclomethasone Clickhaler approved in France

Jan. 28, 2000

New formulation of Xatral receives European approvals

Jan. 28, 2000

FDA approves new labeling for Hyalgan

Jan. 28, 2000

New growth hormone option increases patient convenience

Jan. 25, 2000

Genotropin delivery device now available for long-term replacement therapy in GHD

Jan. 24, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.